Oxidative stress is a common feature of the aging process and of many neurodegenerative disorders, including Alzheimer's disease. Understanding the direct causative relationship between oxidative stress and amyloid pathology, and determining the underlying molecular mechanisms is crucial for the development of more effective therapeutics for the disease. By employing microdialysis technique, we report local increase in the amyloid-β 42 levels and elevated amyloid-β 42/40 ratio in the interstitial fluid within 6 h of direct infusion of oxidizing agents into the hippocampus of living and awake wild type mice. The increase in the amyloid-β 42/40 ratio correlated with the pathogenic conformational change of the amyloid precursor protein-cleaving enzyme, presenilin1/ γ-secretase. Furthermore, we found that the product of lipid peroxidation 4-hydroxynonenal, binds to both nicastrin and BACE, differentially affecting γ-and β-secretase activity, respectively. The present study demonstrates a direct cause-and-effect correlation between oxidative stress and altered amyloid-β production, and provides a molecular mechanism by which naturally occurring product of lipid peroxidation may trigger generation of toxic amyloid-β 42 species.
Introduction
Alzheimer's disease (AD) is an age-related neurodegenerative disorder characterized clinically by progressive memory loss and cognitive decline. The major neuropathological hallmarks of AD are neuronal and synapse loss, accumulation of intraneuronal fibrillary tangles, and deposition of extracellular amyloid plaques consisting of amyloid-β peptide (Aβ) (Hardy and Selkoe, 2002) . Aβ generation is mediated by sequential cleavage of the amyloid precursor protein (APP) by β-secretase (BACE) and γ-secretase. The latter is an enzymatic complex composed of presenilin (PS1 or PS2), nicastrin (NCT), Aph-1 and presenilin enhancer-2 (Pen2) (Bergmans and De Strooper, 2010) . Familial early-onset AD (FAD) is caused by autosomal dominant mutations in presenilin (PSEN1 and PSEN2) and APP genes. However, the sporadic late onset form of AD (SAD) represents the vast majority of the cases, and yet its etiology remains poorly understood. The major nongenetic risk factor involved in the pathogenesis of SAD is aging, which is often accompanied by accumulation of reactive oxygen species (ROS) (Finkel and Holbrook, 2000) . ROS are generated as a result of normal intracellular metabolism and may function as signaling molecules (Nemoto et al., 2000; Nishikawa et al., 2000) . At the same time, a number of external agents such as ultraviolet light or environmental toxins, or internal inflammatory processes can trigger excessive ROS production (Finkel and Holbrook, 2000) . An imbalance due to either increased ROS production or decreased antioxidant defense mechanisms leads to oxidative stress, which damages various cell components via modification of proteins, lipids and DNA, and disrupts numerous cellular processes.
Oxidative damage can be observed in the brain of patients with mild cognitive impairment (MCI) (Lovell and Markesbery, 2001; Butterfield et al., 2006) , a transition stage between normal aging and dementia, and is detected at the early stages of AD (Mangialasche et al., 2009; Reed et al., 2009a Reed et al., , 2009b Sultana and Butterfield, 2010; Sun, 2010; Subramanian et al., 2011) . It has been reported that the level of antioxidant enzymes is diminished, whereas inflammation, ROS production, and the level of oxidative stress markers are elevated in the brain of AD patients, compared to that in the age-matched controls (Sultana and Butterfield, 2010; Krstic and Knuesel, 2013) . Specifically, 4-hydroxynonenal (HNE), an aldehyde product of lipid peroxidation, has been shown to accumulate in the brain due to normal aging, and is present at high levels and believed to be associated with amyloid 
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